|Last Price$69.83||Day Change (%)1.06%|
|Open Price$69.35||Day Change ($)0.73|
|Day Range69.14–69.92||52-Week Range64.78–77.31|
As of Fri 10/24/2014 04:12 PM EST | USD
Research and Markets: Global Biological Drugs Market Outlook 2020
PharmaEngine and Merrimack Amend MM-398 License Agreement
Kamada Announces Second Extension of Strategic Agreement with Baxter
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Research and Markets: Post-Operative Pain Market 2014-2015 - API Manufacturers and Phase III Pipeline Assessment
CAHG Executive Vice President, Chief Creative Officer Robin Shapiro Promoted to President
The diversified health-care firm remains remarkably profitable in tough industries.
While the sector looks fairly valued overall, we still see several stocks that offer attractive valuations across the different industries, including pharmacy benefit managers.